[RDHL] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
14-Nov-2016
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 6.65%
YoY- -27.27%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 1,590 1,359 2,001 100 0 1 1 241.44%
PBT -11,691 -7,684 -10,413 -8,349 -6,560 -5,328 -3,440 22.60%
Tax 212 -364 -787 1,013 -80 0 45 29.46%
NP -11,691 -7,684 -10,413 -8,349 -6,560 -5,328 -3,440 22.60%
Tax Rate - - - - - - - -
Total Cost 13,281 9,043 12,414 8,449 6,560 5,329 3,441 25.23%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -735.28 -565.42 -520.39 -8,349.00 0.00 -532,800.00 -344,000.00 -64.09%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -13.89 -11.68 -20.70 -24.00 -21.04 -24.25 -21.47 -6.99%
EPS Diluted -13.89 -11.68 -20.00 -24.00 -20.64 -24.25 -21.47 -6.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.